Medical Care
Global Next Generation Diabetes Therapy and Drug Delivery Market Research Report 2024
- Jan 26, 24
- ID: 23404
- Pages: 93
- Figures: 193
- Views: 20
Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level.
The global Next Generation Diabetes Therapy and Drug Delivery market was valued at US$ 1757.8 million in 2023 and is anticipated to reach US$ 7852.9 million by 2030, witnessing a CAGR of 23.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Next Generation Diabetes Therapy and Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Diabetes Therapy and Drug Delivery.
Report Scope
The Next Generation Diabetes Therapy and Drug Delivery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next Generation Diabetes Therapy and Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Next Generation Diabetes Therapy and Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Abbott Laboratories
Medtronic
Sanofi
Novo Nordisk
MannKind Corporation
Enteris BioPharma
Dexcom
Senseonics
Medtech
Synertech
Zosano Pharma
Relmada Therapeutics
Eli Lilly and Company
Transdermal Specialties
Segment by Type
Inhalable Insulin
Oral Insulin
Insulin Patches
CGM Systems
Artificial Pancreas
Segment by Application
Diagnostic/Clinics
ICUs
Home Healthcare
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next Generation Diabetes Therapy and Drug Delivery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Next Generation Diabetes Therapy and Drug Delivery market was valued at US$ 1757.8 million in 2023 and is anticipated to reach US$ 7852.9 million by 2030, witnessing a CAGR of 23.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Next Generation Diabetes Therapy and Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Diabetes Therapy and Drug Delivery.
Report Scope
The Next Generation Diabetes Therapy and Drug Delivery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next Generation Diabetes Therapy and Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Next Generation Diabetes Therapy and Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Abbott Laboratories
Medtronic
Sanofi
Novo Nordisk
MannKind Corporation
Enteris BioPharma
Dexcom
Senseonics
Medtech
Synertech
Zosano Pharma
Relmada Therapeutics
Eli Lilly and Company
Transdermal Specialties
Segment by Type
Inhalable Insulin
Oral Insulin
Insulin Patches
CGM Systems
Artificial Pancreas
Segment by Application
Diagnostic/Clinics
ICUs
Home Healthcare
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next Generation Diabetes Therapy and Drug Delivery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Inhalable Insulin
1.2.3 Oral Insulin
1.2.4 Insulin Patches
1.2.5 CGM Systems
1.2.6 Artificial Pancreas
1.3 Market by Application
1.3.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostic/Clinics
1.3.3 ICUs
1.3.4 Home Healthcare
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Perspective (2019-2030)
2.2 Next Generation Diabetes Therapy and Drug Delivery Growth Trends by Region
2.2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Region (2019-2024)
2.2.3 Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Region (2025-2030)
2.3 Next Generation Diabetes Therapy and Drug Delivery Market Dynamics
2.3.1 Next Generation Diabetes Therapy and Drug Delivery Industry Trends
2.3.2 Next Generation Diabetes Therapy and Drug Delivery Market Drivers
2.3.3 Next Generation Diabetes Therapy and Drug Delivery Market Challenges
2.3.4 Next Generation Diabetes Therapy and Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Revenue
3.1.1 Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Revenue (2019-2024)
3.1.2 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Players (2019-2024)
3.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next Generation Diabetes Therapy and Drug Delivery Revenue
3.4 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio
3.4.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Diabetes Therapy and Drug Delivery Revenue in 2023
3.5 Next Generation Diabetes Therapy and Drug Delivery Key Players Head office and Area Served
3.6 Key Players Next Generation Diabetes Therapy and Drug Delivery Product Solution and Service
3.7 Date of Enter into Next Generation Diabetes Therapy and Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Diabetes Therapy and Drug Delivery Breakdown Data by Type
4.1 Global Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Type (2019-2024)
4.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2025-2030)
5 Next Generation Diabetes Therapy and Drug Delivery Breakdown Data by Application
5.1 Global Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Application (2019-2024)
5.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Next Generation Diabetes Therapy and Drug Delivery Market Size (2019-2030)
6.2 North America Next Generation Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024)
6.4 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size (2019-2030)
7.2 Europe Next Generation Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024)
7.4 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size (2019-2030)
8.2 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2019-2024)
8.4 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size (2019-2030)
9.2 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024)
9.4 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size (2019-2030)
10.2 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024)
10.4 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Introduction
11.1.4 Johnson & Johnson Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.1.5 Johnson & Johnson Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Introduction
11.2.4 Abbott Laboratories Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.2.5 Abbott Laboratories Recent Development
11.3 Medtronic
11.3.1 Medtronic Company Detail
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Introduction
11.3.4 Medtronic Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.3.5 Medtronic Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Introduction
11.4.4 Sanofi Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.4.5 Sanofi Recent Development
11.5 Novo Nordisk
11.5.1 Novo Nordisk Company Detail
11.5.2 Novo Nordisk Business Overview
11.5.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Introduction
11.5.4 Novo Nordisk Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.5.5 Novo Nordisk Recent Development
11.6 MannKind Corporation
11.6.1 MannKind Corporation Company Detail
11.6.2 MannKind Corporation Business Overview
11.6.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Introduction
11.6.4 MannKind Corporation Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.6.5 MannKind Corporation Recent Development
11.7 Enteris BioPharma
11.7.1 Enteris BioPharma Company Detail
11.7.2 Enteris BioPharma Business Overview
11.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Introduction
11.7.4 Enteris BioPharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.7.5 Enteris BioPharma Recent Development
11.8 Dexcom
11.8.1 Dexcom Company Detail
11.8.2 Dexcom Business Overview
11.8.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Introduction
11.8.4 Dexcom Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.8.5 Dexcom Recent Development
11.9 Senseonics
11.9.1 Senseonics Company Detail
11.9.2 Senseonics Business Overview
11.9.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Introduction
11.9.4 Senseonics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.9.5 Senseonics Recent Development
11.10 Medtech
11.10.1 Medtech Company Detail
11.10.2 Medtech Business Overview
11.10.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Introduction
11.10.4 Medtech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.10.5 Medtech Recent Development
11.11 Synertech
11.11.1 Synertech Company Detail
11.11.2 Synertech Business Overview
11.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Introduction
11.11.4 Synertech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.11.5 Synertech Recent Development
11.12 Zosano Pharma
11.12.1 Zosano Pharma Company Detail
11.12.2 Zosano Pharma Business Overview
11.12.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Introduction
11.12.4 Zosano Pharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.12.5 Zosano Pharma Recent Development
11.13 Relmada Therapeutics
11.13.1 Relmada Therapeutics Company Detail
11.13.2 Relmada Therapeutics Business Overview
11.13.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Introduction
11.13.4 Relmada Therapeutics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.13.5 Relmada Therapeutics Recent Development
11.14 Eli Lilly and Company
11.14.1 Eli Lilly and Company Company Detail
11.14.2 Eli Lilly and Company Business Overview
11.14.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Introduction
11.14.4 Eli Lilly and Company Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.14.5 Eli Lilly and Company Recent Development
11.15 Transdermal Specialties
11.15.1 Transdermal Specialties Company Detail
11.15.2 Transdermal Specialties Business Overview
11.15.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Introduction
11.15.4 Transdermal Specialties Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.15.5 Transdermal Specialties Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Inhalable Insulin
1.2.3 Oral Insulin
1.2.4 Insulin Patches
1.2.5 CGM Systems
1.2.6 Artificial Pancreas
1.3 Market by Application
1.3.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostic/Clinics
1.3.3 ICUs
1.3.4 Home Healthcare
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Perspective (2019-2030)
2.2 Next Generation Diabetes Therapy and Drug Delivery Growth Trends by Region
2.2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Region (2019-2024)
2.2.3 Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Region (2025-2030)
2.3 Next Generation Diabetes Therapy and Drug Delivery Market Dynamics
2.3.1 Next Generation Diabetes Therapy and Drug Delivery Industry Trends
2.3.2 Next Generation Diabetes Therapy and Drug Delivery Market Drivers
2.3.3 Next Generation Diabetes Therapy and Drug Delivery Market Challenges
2.3.4 Next Generation Diabetes Therapy and Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Revenue
3.1.1 Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Revenue (2019-2024)
3.1.2 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Players (2019-2024)
3.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next Generation Diabetes Therapy and Drug Delivery Revenue
3.4 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio
3.4.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Diabetes Therapy and Drug Delivery Revenue in 2023
3.5 Next Generation Diabetes Therapy and Drug Delivery Key Players Head office and Area Served
3.6 Key Players Next Generation Diabetes Therapy and Drug Delivery Product Solution and Service
3.7 Date of Enter into Next Generation Diabetes Therapy and Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Diabetes Therapy and Drug Delivery Breakdown Data by Type
4.1 Global Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Type (2019-2024)
4.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2025-2030)
5 Next Generation Diabetes Therapy and Drug Delivery Breakdown Data by Application
5.1 Global Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Application (2019-2024)
5.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Next Generation Diabetes Therapy and Drug Delivery Market Size (2019-2030)
6.2 North America Next Generation Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024)
6.4 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size (2019-2030)
7.2 Europe Next Generation Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024)
7.4 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size (2019-2030)
8.2 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2019-2024)
8.4 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size (2019-2030)
9.2 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024)
9.4 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size (2019-2030)
10.2 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024)
10.4 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Introduction
11.1.4 Johnson & Johnson Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.1.5 Johnson & Johnson Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Introduction
11.2.4 Abbott Laboratories Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.2.5 Abbott Laboratories Recent Development
11.3 Medtronic
11.3.1 Medtronic Company Detail
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Introduction
11.3.4 Medtronic Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.3.5 Medtronic Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Introduction
11.4.4 Sanofi Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.4.5 Sanofi Recent Development
11.5 Novo Nordisk
11.5.1 Novo Nordisk Company Detail
11.5.2 Novo Nordisk Business Overview
11.5.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Introduction
11.5.4 Novo Nordisk Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.5.5 Novo Nordisk Recent Development
11.6 MannKind Corporation
11.6.1 MannKind Corporation Company Detail
11.6.2 MannKind Corporation Business Overview
11.6.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Introduction
11.6.4 MannKind Corporation Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.6.5 MannKind Corporation Recent Development
11.7 Enteris BioPharma
11.7.1 Enteris BioPharma Company Detail
11.7.2 Enteris BioPharma Business Overview
11.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Introduction
11.7.4 Enteris BioPharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.7.5 Enteris BioPharma Recent Development
11.8 Dexcom
11.8.1 Dexcom Company Detail
11.8.2 Dexcom Business Overview
11.8.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Introduction
11.8.4 Dexcom Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.8.5 Dexcom Recent Development
11.9 Senseonics
11.9.1 Senseonics Company Detail
11.9.2 Senseonics Business Overview
11.9.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Introduction
11.9.4 Senseonics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.9.5 Senseonics Recent Development
11.10 Medtech
11.10.1 Medtech Company Detail
11.10.2 Medtech Business Overview
11.10.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Introduction
11.10.4 Medtech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.10.5 Medtech Recent Development
11.11 Synertech
11.11.1 Synertech Company Detail
11.11.2 Synertech Business Overview
11.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Introduction
11.11.4 Synertech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.11.5 Synertech Recent Development
11.12 Zosano Pharma
11.12.1 Zosano Pharma Company Detail
11.12.2 Zosano Pharma Business Overview
11.12.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Introduction
11.12.4 Zosano Pharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.12.5 Zosano Pharma Recent Development
11.13 Relmada Therapeutics
11.13.1 Relmada Therapeutics Company Detail
11.13.2 Relmada Therapeutics Business Overview
11.13.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Introduction
11.13.4 Relmada Therapeutics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.13.5 Relmada Therapeutics Recent Development
11.14 Eli Lilly and Company
11.14.1 Eli Lilly and Company Company Detail
11.14.2 Eli Lilly and Company Business Overview
11.14.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Introduction
11.14.4 Eli Lilly and Company Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.14.5 Eli Lilly and Company Recent Development
11.15 Transdermal Specialties
11.15.1 Transdermal Specialties Company Detail
11.15.2 Transdermal Specialties Business Overview
11.15.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Introduction
11.15.4 Transdermal Specialties Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.15.5 Transdermal Specialties Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Inhalable Insulin
Table 3. Key Players of Oral Insulin
Table 4. Key Players of Insulin Patches
Table 5. Key Players of CGM Systems
Table 6. Key Players of Artificial Pancreas
Table 7. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Region (2019-2024)
Table 11. Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Region (2025-2030)
Table 13. Next Generation Diabetes Therapy and Drug Delivery Market Trends
Table 14. Next Generation Diabetes Therapy and Drug Delivery Market Drivers
Table 15. Next Generation Diabetes Therapy and Drug Delivery Market Challenges
Table 16. Next Generation Diabetes Therapy and Drug Delivery Market Restraints
Table 17. Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Players (2019-2024)
Table 19. Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Diabetes Therapy and Drug Delivery as of 2023)
Table 20. Ranking of Global Top Next Generation Diabetes Therapy and Drug Delivery Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Next Generation Diabetes Therapy and Drug Delivery Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Next Generation Diabetes Therapy and Drug Delivery Product Solution and Service
Table 24. Date of Enter into Next Generation Diabetes Therapy and Drug Delivery Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2019-2024)
Table 28. Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2025-2030)
Table 30. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2019-2024)
Table 32. Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2025-2030)
Table 34. North America Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 49. Johnson & Johnson Company Detail
Table 50. Johnson & Johnson Business Overview
Table 51. Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Product
Table 52. Johnson & Johnson Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 53. Johnson & Johnson Recent Development
Table 54. Abbott Laboratories Company Detail
Table 55. Abbott Laboratories Business Overview
Table 56. Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Product
Table 57. Abbott Laboratories Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 58. Abbott Laboratories Recent Development
Table 59. Medtronic Company Detail
Table 60. Medtronic Business Overview
Table 61. Medtronic Next Generation Diabetes Therapy and Drug Delivery Product
Table 62. Medtronic Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 63. Medtronic Recent Development
Table 64. Sanofi Company Detail
Table 65. Sanofi Business Overview
Table 66. Sanofi Next Generation Diabetes Therapy and Drug Delivery Product
Table 67. Sanofi Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 68. Sanofi Recent Development
Table 69. Novo Nordisk Company Detail
Table 70. Novo Nordisk Business Overview
Table 71. Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Product
Table 72. Novo Nordisk Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 73. Novo Nordisk Recent Development
Table 74. MannKind Corporation Company Detail
Table 75. MannKind Corporation Business Overview
Table 76. MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Product
Table 77. MannKind Corporation Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 78. MannKind Corporation Recent Development
Table 79. Enteris BioPharma Company Detail
Table 80. Enteris BioPharma Business Overview
Table 81. Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Product
Table 82. Enteris BioPharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 83. Enteris BioPharma Recent Development
Table 84. Dexcom Company Detail
Table 85. Dexcom Business Overview
Table 86. Dexcom Next Generation Diabetes Therapy and Drug Delivery Product
Table 87. Dexcom Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 88. Dexcom Recent Development
Table 89. Senseonics Company Detail
Table 90. Senseonics Business Overview
Table 91. Senseonics Next Generation Diabetes Therapy and Drug Delivery Product
Table 92. Senseonics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 93. Senseonics Recent Development
Table 94. Medtech Company Detail
Table 95. Medtech Business Overview
Table 96. Medtech Next Generation Diabetes Therapy and Drug Delivery Product
Table 97. Medtech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 98. Medtech Recent Development
Table 99. Synertech Company Detail
Table 100. Synertech Business Overview
Table 101. Synertech Next Generation Diabetes Therapy and Drug Delivery Product
Table 102. Synertech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 103. Synertech Recent Development
Table 104. Zosano Pharma Company Detail
Table 105. Zosano Pharma Business Overview
Table 106. Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Product
Table 107. Zosano Pharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 108. Zosano Pharma Recent Development
Table 109. Relmada Therapeutics Company Detail
Table 110. Relmada Therapeutics Business Overview
Table 111. Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Product
Table 112. Relmada Therapeutics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 113. Relmada Therapeutics Recent Development
Table 114. Eli Lilly and Company Company Detail
Table 115. Eli Lilly and Company Business Overview
Table 116. Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Product
Table 117. Eli Lilly and Company Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 118. Eli Lilly and Company Recent Development
Table 119. Transdermal Specialties Company Detail
Table 120. Transdermal Specialties Business Overview
Table 121. Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Product
Table 122. Transdermal Specialties Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 123. Transdermal Specialties Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Type: 2023 VS 2030
Figure 3. Inhalable Insulin Features
Figure 4. Oral Insulin Features
Figure 5. Insulin Patches Features
Figure 6. CGM Systems Features
Figure 7. Artificial Pancreas Features
Figure 8. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Application: 2023 VS 2030
Figure 10. Diagnostic/Clinics Case Studies
Figure 11. ICUs Case Studies
Figure 12. Home Healthcare Case Studies
Figure 13. Next Generation Diabetes Therapy and Drug Delivery Report Years Considered
Figure 14. Global Next Generation Diabetes Therapy and Drug Delivery Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Next Generation Diabetes Therapy and Drug Delivery Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Region: 2023 VS 2030
Figure 17. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Players in 2023
Figure 18. Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Diabetes Therapy and Drug Delivery as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Next Generation Diabetes Therapy and Drug Delivery Revenue in 2023
Figure 20. North America Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Next Generation Diabetes Therapy and Drug Delivery Market Share by Country (2019-2030)
Figure 22. United States Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Next Generation Diabetes Therapy and Drug Delivery Market Share by Country (2019-2030)
Figure 26. Germany Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Share by Region (2019-2030)
Figure 34. China Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Share by Country (2019-2030)
Figure 42. Mexico Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Share by Country (2019-2030)
Figure 46. Turkey Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Johnson & Johnson Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 49. Abbott Laboratories Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 50. Medtronic Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 51. Sanofi Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 52. Novo Nordisk Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 53. MannKind Corporation Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 54. Enteris BioPharma Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 55. Dexcom Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 56. Senseonics Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 57. Medtech Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 58. Synertech Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 59. Zosano Pharma Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 60. Relmada Therapeutics Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 61. Eli Lilly and Company Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 62. Transdermal Specialties Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Inhalable Insulin
Table 3. Key Players of Oral Insulin
Table 4. Key Players of Insulin Patches
Table 5. Key Players of CGM Systems
Table 6. Key Players of Artificial Pancreas
Table 7. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Region (2019-2024)
Table 11. Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Region (2025-2030)
Table 13. Next Generation Diabetes Therapy and Drug Delivery Market Trends
Table 14. Next Generation Diabetes Therapy and Drug Delivery Market Drivers
Table 15. Next Generation Diabetes Therapy and Drug Delivery Market Challenges
Table 16. Next Generation Diabetes Therapy and Drug Delivery Market Restraints
Table 17. Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Players (2019-2024)
Table 19. Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Diabetes Therapy and Drug Delivery as of 2023)
Table 20. Ranking of Global Top Next Generation Diabetes Therapy and Drug Delivery Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Next Generation Diabetes Therapy and Drug Delivery Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Next Generation Diabetes Therapy and Drug Delivery Product Solution and Service
Table 24. Date of Enter into Next Generation Diabetes Therapy and Drug Delivery Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2019-2024)
Table 28. Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2025-2030)
Table 30. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2019-2024)
Table 32. Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2025-2030)
Table 34. North America Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 49. Johnson & Johnson Company Detail
Table 50. Johnson & Johnson Business Overview
Table 51. Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Product
Table 52. Johnson & Johnson Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 53. Johnson & Johnson Recent Development
Table 54. Abbott Laboratories Company Detail
Table 55. Abbott Laboratories Business Overview
Table 56. Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Product
Table 57. Abbott Laboratories Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 58. Abbott Laboratories Recent Development
Table 59. Medtronic Company Detail
Table 60. Medtronic Business Overview
Table 61. Medtronic Next Generation Diabetes Therapy and Drug Delivery Product
Table 62. Medtronic Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 63. Medtronic Recent Development
Table 64. Sanofi Company Detail
Table 65. Sanofi Business Overview
Table 66. Sanofi Next Generation Diabetes Therapy and Drug Delivery Product
Table 67. Sanofi Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 68. Sanofi Recent Development
Table 69. Novo Nordisk Company Detail
Table 70. Novo Nordisk Business Overview
Table 71. Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Product
Table 72. Novo Nordisk Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 73. Novo Nordisk Recent Development
Table 74. MannKind Corporation Company Detail
Table 75. MannKind Corporation Business Overview
Table 76. MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Product
Table 77. MannKind Corporation Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 78. MannKind Corporation Recent Development
Table 79. Enteris BioPharma Company Detail
Table 80. Enteris BioPharma Business Overview
Table 81. Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Product
Table 82. Enteris BioPharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 83. Enteris BioPharma Recent Development
Table 84. Dexcom Company Detail
Table 85. Dexcom Business Overview
Table 86. Dexcom Next Generation Diabetes Therapy and Drug Delivery Product
Table 87. Dexcom Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 88. Dexcom Recent Development
Table 89. Senseonics Company Detail
Table 90. Senseonics Business Overview
Table 91. Senseonics Next Generation Diabetes Therapy and Drug Delivery Product
Table 92. Senseonics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 93. Senseonics Recent Development
Table 94. Medtech Company Detail
Table 95. Medtech Business Overview
Table 96. Medtech Next Generation Diabetes Therapy and Drug Delivery Product
Table 97. Medtech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 98. Medtech Recent Development
Table 99. Synertech Company Detail
Table 100. Synertech Business Overview
Table 101. Synertech Next Generation Diabetes Therapy and Drug Delivery Product
Table 102. Synertech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 103. Synertech Recent Development
Table 104. Zosano Pharma Company Detail
Table 105. Zosano Pharma Business Overview
Table 106. Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Product
Table 107. Zosano Pharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 108. Zosano Pharma Recent Development
Table 109. Relmada Therapeutics Company Detail
Table 110. Relmada Therapeutics Business Overview
Table 111. Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Product
Table 112. Relmada Therapeutics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 113. Relmada Therapeutics Recent Development
Table 114. Eli Lilly and Company Company Detail
Table 115. Eli Lilly and Company Business Overview
Table 116. Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Product
Table 117. Eli Lilly and Company Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 118. Eli Lilly and Company Recent Development
Table 119. Transdermal Specialties Company Detail
Table 120. Transdermal Specialties Business Overview
Table 121. Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Product
Table 122. Transdermal Specialties Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)
Table 123. Transdermal Specialties Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Type: 2023 VS 2030
Figure 3. Inhalable Insulin Features
Figure 4. Oral Insulin Features
Figure 5. Insulin Patches Features
Figure 6. CGM Systems Features
Figure 7. Artificial Pancreas Features
Figure 8. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Application: 2023 VS 2030
Figure 10. Diagnostic/Clinics Case Studies
Figure 11. ICUs Case Studies
Figure 12. Home Healthcare Case Studies
Figure 13. Next Generation Diabetes Therapy and Drug Delivery Report Years Considered
Figure 14. Global Next Generation Diabetes Therapy and Drug Delivery Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Next Generation Diabetes Therapy and Drug Delivery Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Region: 2023 VS 2030
Figure 17. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Players in 2023
Figure 18. Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Diabetes Therapy and Drug Delivery as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Next Generation Diabetes Therapy and Drug Delivery Revenue in 2023
Figure 20. North America Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Next Generation Diabetes Therapy and Drug Delivery Market Share by Country (2019-2030)
Figure 22. United States Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Next Generation Diabetes Therapy and Drug Delivery Market Share by Country (2019-2030)
Figure 26. Germany Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Share by Region (2019-2030)
Figure 34. China Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Share by Country (2019-2030)
Figure 42. Mexico Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Share by Country (2019-2030)
Figure 46. Turkey Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Johnson & Johnson Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 49. Abbott Laboratories Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 50. Medtronic Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 51. Sanofi Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 52. Novo Nordisk Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 53. MannKind Corporation Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 54. Enteris BioPharma Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 55. Dexcom Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 56. Senseonics Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 57. Medtech Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 58. Synertech Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 59. Zosano Pharma Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 60. Relmada Therapeutics Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 61. Eli Lilly and Company Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 62. Transdermal Specialties Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232